BioMarin to Present at 38th Annual J.P. Morgan Healthcare Conference in San FranciscoHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)BioMarin to Present at 38th Annual J.P. Morgan Healthcare Conference in San FranciscoPR NewswireJanuary 6, 2020ReblogShareTweetShareSAN RAFAEL, Calif., Jan. 6, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 7:30 am PT, or 10:30 am ET, in San Francisco, California. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following the event.BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)MoreAbout BioMarinBioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release. Contacts:
Investors
Media
Traci McCarty
Debra Charlesworth
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
(415) 455-7558
(415) 455-7451
CisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-present-at-38th-annual-jp-morgan-healthcare-conference-in-san-francisco-300978584.htmlSOURCE BioMarin Pharmaceutical Inc.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBioMarin (BMRN) Q4 Earnings Beat, Sales Miss, Valrox in FocusZacksStock Market News for Feb 27, 2020ZacksBioMarin Pharmaceutical (BMRN) Q4 Earnings Top EstimatesZacksBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoFed seen cutting rates amid virus threat, low inflationReutersStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoWhat Does TL Natural Gas Holdings Limited’s (HKG:8536) 14% ROCE Say About The Business?Simply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo Finance